trending Market Intelligence /marketintelligence/en/news-insights/trending/zk2bik3il5feq0ogsge_xg2 content esgSubNav
In This List

TearLab to delist from Toronto Stock Exchange

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


TearLab to delist from Toronto Stock Exchange

TearLab Corp. said it will delist from the Toronto Stock Exchange, effective March 29, subject to approval from the regulator.

The San Diego-based diagnostics company said it will be unable to regain compliance with TSX's continued listing requirements by the March 29 deadline.

The company said its stock will remain listed on the OTCQB under the symbol TEAR.

TearLab said the costs associated with maintaining a dual listing were "no longer justified" while the company works toward conserving resources and streamlining its operations.

In November 2017, the company said it would delist its securities from the Nasdaq Capital Market due to continued noncompliance with the exchange's listing requirements.